PharmaCyte Biotech (PMCB) Other Accumulated Expenses (2009 - 2026)
PharmaCyte Biotech (PMCB) reported Other Accumulated Expenses of $287,310 for fiscal Q1 2024 (quarter ended Jul 31, 2023), down 23.8% from $377,155 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
Dating back to fiscal Q1 2013, PharmaCyte Biotech's Other Accumulated Expenses record includes 15 quarters.
- By fiscal year, Other Accumulated Expenses came in at $377,155 in FY2022.
- Five-year quarterly Other Accumulated Expenses spans a low of $287,310 in fiscal Q3 2023 and a high of $467,000 in fiscal Q3 2022.
- Year over year, Other Accumulated Expenses has now declined in each of the last three quarters.
- Per Business Quant data, the three fiscal quarters before Q1 2024 came in at $287,310 (Q4 2023), $287,310 (Q3 2023) and $377,155 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 391,301.00 |
| Apr 30, 2025 | 438,416.00 |
| Jul 31, 2023 | 287,310.00 |
| Apr 30, 2023 | 287,310.00 |
| Jan 31, 2023 | 287,310.00 |
| Oct 31, 2022 | 377,155.00 |
| Jul 31, 2022 | 377,155.00 |
| Apr 30, 2022 | 377,155.00 |
| Jan 31, 2022 | 467,000.00 |
| Jan 31, 2021 | 595,976.00 |
| Oct 31, 2020 | 421,888.00 |
| Apr 30, 2020 | 301,221.00 |
| Jan 31, 2020 | 203,566.00 |
| Oct 31, 2019 | 90,270.00 |
| Jul 31, 2019 | 72,330.00 |
| Apr 30, 2019 | 460,052.00 |
| Jan 31, 2019 | 442,039.00 |
| Jul 31, 2018 | 267,794.00 |
| Apr 30, 2018 | 2.00 Mn |
| Jan 31, 2018 | 1.75 Mn |
API Access
PharmaCyte Biotech Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();